One hallmark of systemic lupus erythematosus (SLE) is the presence of autoantibodies directed at a diverse group of proteins of the U1/Sm small nuclear ribonucleoprotein particles (snRNP). Patients with SLE and murine models of this disease generate high titers of af®nity mature, isotype-switched autoantibodies characteristic of T cell-dependent immune responses. In this investigation, we made use of anti-snRNP Ig transgenic mice (2-12 Tg) to track regulation of autoreactive B cells in normal and autoimmune-prone mice. Autoantibody studies demonstrated that the regulation of anti-snRNP B cells is intact in non-autoimmune Tg mice, but not in MRL-lpr/ lpr mice. We further utilize autoreactive Tg B cells as antigen-presenting cells (APC) and individual snRNP peptides to assess the presence of autoreactive T cells in the repertoire of non-autoimmune and MRL-lpr/lpr mice. We found that Tg B cells can direct speci®c T cell tolerance in a nonautoimmune-prone (C57Bl/6) background, whereas the same autoantibody transgene in MRL-lpr/lpr mice drives T cell autoimmunity. Moreover, Tg B cell APC could stimulate autoreactive T cells from wild-type (non-Tg) C57Bl/6 mice, indicating a lack of tolerance induction in the absence of the autoantigenic-presenting B cells. Thus, we have de®ned dual roles for autoantigen-presenting B lymphocytes in stimulating self-reactive T cells that inhabit the normal repertoire or, under some conditions, providing tolerance signals.
Introduction
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the presence of autoantibodies to a number of common cytoplasmic and nuclear components (1) . One important target of autoimmune responses in human SLE and in murine models of the disease is a group of small nuclear ribonucleoprotein particles (snRNP) designated U1 and Sm (2±4). Patients with SLE have autoantibodies that are directed at a diverse array of determinants on the 70-kDa, A and C protein components of the U1 snRNP and the B/B¢ and D protein of the Sm snRNP. These autoantibody responses are typical of other antigen-driven immune responses in their isotype expression, their degree of somatic mutation and their dependence on CD4 T h cell responses (5±8).
In addition to their functions in antibody synthesis, B cells are also effective antigen-presenting cells (APC). Surface Ig receptor uptake of speci®c antigen can stimulate T lymphocytes nearly 10,000-fold more ef®ciently than non-speci®c APC (9, 10) . We and others have previously found that this property has important implications in the induction of autoimmune responses (11±16). B cells with the ability to concentrate self-antigens may activate T cells that are in low numbers or have low af®nity for self-peptide in the periphery. It is already clear that the threshold of self-antigen and/or af®nity for self-peptides helps de®ne central T cell development in the thymus. Moreover, support for an active role of B cells in lupus pathogenesis has been elucidated by the analysis of B cellde®cient (JhD) MRL-lpr/lpr mice (15, 16) . B cell-de®cient MRLlpr/lpr mice do not develop populations of activated T cells as are found spontaneously in wild-type mice. The reconstitution of JhD MRL-lpr/lpr mice with B cells that do not secrete Ig reconstitutes T cell activation in a manner comparable to wildtype MRL-lpr/lpr mice. These studies suggest that B cells play a central role in the promotion of systemic autoimmunity by the direct activation of autoreactive CD4 T cells through the presentation of autoantigenic peptides.
As demonstrated by other investigators, B cells may also have a role in the induction of peripheral T cell tolerance (17± 21). These seemingly contradictory roles for B cells have been dif®cult to fully resolve. In vitro and in vivo studies using resting or previously activated populations of T and B cells suggest that the outcomes of this cognate interaction may be dependent on a number of factors, including the activation status of both T and B cells during their initial encounter (22, 23) . Our own prior studies implicate a requirement for surface B7± CD28 interactions when B cells prime autoreactive T cells in normal mouse strains (24) . However, autoimmune-prone MRL mice develop activated T cells, high titers of autoantibodies and pathology in the complete absence of B7-1 and B7-2 (25, 26) . In either case, whether in the induction of T cell tolerance or activation, self-reactive B cells must survive selective pressures of their own to perform these functions. Studies using Ig transgenes directed towards the model antigen hen egg lysozyme, MHC class I or the doublestranded DNA autoantigen of lupus have observed several developmental outcomes for autoreactive B cells in nonautoimmune mice. Among these transgenic (Tg) models, selfreactive B cells may experience clonal deletion, anergy or receptor editing and may be receptive to stimulation with selfantigen (27±36). A model utilizing rheumatoid factor Ig transgenes has demonstrated immunologic`ignorance' that could be overcome in the presence of the stimulating autoantigen (37) .
In the present study, we have utilized autoantibody Tg mice on both normal and autoimmune-prone murine backgrounds in attempts to identify features that may dictate the induction of T cell tolerance versus autoimmunity. Anti-snRNP Ig m chain Tg (2-12 Tg) mice have been developed previously using an unmutated, rearranged VhJ558 gene derived from an MRLlpr/lpr anti-Sm hybridoma designated 2-12 (32). The 2-12 Ig transgene supports B cell development with about one-third of the Tg B cell repertoire responsive to the self-snRNP autoantigen. Anti-snRNP B cells in a normal background are developmentally arrested but can produce autoantibodies in response to immunization with the snRNP autoantigen, while anti-snRNP Tg B cells in MRL-lpr/lpr mice spontaneously produce autoantibodies. Using this model, we demonstrate that anti-snRNP B cells are capable of tolerizing autoreactive T cells in normal, non-autoimmune strains of mice. However, the same transgene leads to T cell activation to the snRNP antigen in autoimmune-prone MRL-lpr/lpr mice. The differential Syk kinase phosphorylation of anti-snRNP B cells from normal background mice versus autoimmune-prone mice may at least in part explain the different outcome of autoreactive T cells. Thus, these studies support the premise that receptor-mediated uptake of self-antigen by B cells is critical in the induction of either tolerance or autoimmunity as well as the speci®city of autoreactive T cells.
Methods

Ig Tg mice
Anti-snRNP B cell hybridoma, designated 2-12, was originally cloned from an MRL-lpr/lpr mouse (38) . Ig Tg mice were derived using the rearranged VDJ segment of the 2-12 antisnRNP hybridoma cloned upstream in a vector containing the C m region gene segment. Tg founders were backcrossed for >10 generations to B10.A, C57BL/6 mice or MRL-lpr/lpr mice. Presence of the transgene was identi®ed by PCR analysis of tail DNA using 2-12-speci®c primers 5¢-GAGGTCCAGCTG-CAGCAGTCTGGA-3¢ in the ®rst coding region of the V region and 5¢-CGCTCCACCAGACCTCTCTAGA-3¢ complementary to the XbaI site downstream of JH4. Animals were age and sex matched in all experiments, and housed in a conventional facility at Yale University.
Indirect immuno¯uorescence (antinuclear antibodies)
Indirect immuno¯uorescence assays were performed using commercially available cell substrates (Inova, San Diego, CA). In brief, 40 ml of a 1:40 dilution of serum was placed on slides coated with human epithelial cells (HEp-2) and incubated at room temperature for 2 h. After a 5-min wash in PBS, FITCconjugated anti-mouse IgM or IgG (Sigma, St Louis, MO) was applied to individual wells and incubated in the dark at room temperature for 2 h. After another 5-min wash, wells were examined by UV-¯uorescence microscopy.
Measurement of anti-snRNP response by ELISA
Detection of anti-snRNP by ELISA was performed as previously described (25) . Brie¯y, 96-well PVC plates were coated with native snRNP antigen in carbonate-buffered saline, washed and blocked with PBS/BSA/Tween. Mouse sera were diluted at 1:100 in PBS and then added to antigencoated plates in duplicate. Anti-mouse IgM±alkaline phosphatase (Southern Biotechnology Associates, Birmingham, AL) was used as secondary antibody and diluted at 1:1000. Assays were developed with 1 mg/ml p-nitrophenylphosphate (Sigma) and the OD 405 determined at various timepoints. Experimental values from separate experiments were normalized to a single MRL-lpr/lpr positive control serum used in every assay (arbitrarily de®ned as 100 U).
Kidney pathology
Kidneys from Tg or wild-type mice were collected at the indicated timepoints and immediately immersed in 10% formalin (Fisher, Pittsburgh, PA). Thin sections and H & E staining were performed by Yale Dermatopathology Laboratory. Blinded samples were examined for pathology at Q100 magni®cation.
Lymphocyte proliferation assays
Conventional T lymphocyte proliferation assays were performed with puri®ed CD4 T cells (2±3 Q 10 6 cells/ml) and irradiated puri®ed B cells (500 rad) as APC (8±12 Q 10 6 cells/ ml). All assays were set up with triplicate samples and incubated with antigen titrations for 4 days. Lymphocyte proliferation was assessed by [ 3 H]thymidine incorporation (1.0 mCi/well; ICN, Irvine, CA) during the last 18 h of culture. Sample wells were harvested onto ®lters and incorporated radioactivity was counted in a Betaplate liquid scintillation counter (LKB/Wallac, Gaithersburg, MD).
CD4 T cells were puri®ed using a two-step protocol. Unfractionated spleen cells were incubated with a cocktail of antibodies to CD8 (TIB208), B cells (TIB146), monocytes/ macrophages (TIB128) and anti-class II antibodies (Y3JP) at 4°C for 1 h. Excess antibodies were washed off followed by incubation with sheep anti-mouse/rat Ig-coated magnetic beads (Perseptive Biosystems, Cambridge, MA) at a ratio of 5:1 (beads:cells) for 1 h at 4°C. The unbound CD4 cells were separated from other cell populations on a magnet and the unbound cells were then subjected to a second round of puri®cation as described above. The purity of CD4 cells was >96% as assessed by¯ow cytometry.
B cell puri®cation
B cells were puri®ed using negative selection and magnetic beads. In brief, lymphocytes from splenocytes were enriched by Ficoll-Hypaque (Sigma) density separation. Cells were labeled with anti-mouse CD43 and anti-mouse CD90 microbeads (Miltenyi Biotech, Auburn, CA) and passed through a separation column that is placed in the magnetic ®eld of a MACS separator. The purity of B cells was >95% as assessed by¯ow cytometry.
Generation and analysis of T cell hybridomas
T cell hybridomas were derived from unmanipulated MRL-lpr/ lpr 2-12 Tg mice. These mice were sacri®ced and splenocytes were fused with the BW 5147 T cell thymoma cell line to generate T cell hybridomas. T cell hybridomas that stained positive for the TCR were used for further screening. The T cell hybridomas were then assayed for speci®city using APC from 2-12 Tg mice and pools of snRNP D peptides (Yale University, Keck Laboratory of Protein Synthesis) as sources of antigen. All assays were set up in triplicate and supernatants from these cultures were harvested 24 h later and assayed for IL-2 production using the CTLL cell line. CTLL cell proliferation was assessed by [ 3 H]thymidine incorporation as described above. Hybridomas that responded to snRNP D peptides presented by 2-12 Tg APC were used in subsequent assays.
Antigens and immunizations
Synthetic peptides of the D protein of the murine snRNP and recombinant murine D (rD) protein expressed in Escherichia coli were used as sources of antigen in T cell proliferation assays. A total of 22 peptides (15mers) of the murine snRNP D protein were synthesized for the analysis of T cell speci®city. Peptides overlapped by ®ve amino acids along the entire length of the D protein. To express rD protein, the cDNA encoding the open reading frame of the snRNP D gene was cloned by PCR from a murine cDNA library. The snRNP D cDNA was subcloned into the vector pBluescript II KS (Stratagene, La Jolla, CA). Sequencing by the Sanger dideoxynucleotide method con®rmed that the 372-bp cDNA was identical to that of the published sequence of murine snRNP D (39) . rD was expressed in induced E. coli and puri®ed by anion-exchange chromatography as described previously (39) . rD protein was absorbed for potential mitogens by anti-lipopolysaccharide column chromatography using agarose beads coated with Polymyxin B. Part of the rD preparation was labeled with biotin for FACS staining or tissue section staining.
In some experiments, wild-type or Tg C57Bl/6 mice were immunized with rD protein followed by examination of serum antibodies by ELISA. For these studies, groups of ®ve wildtype or Tg C57Bl/6 mice were immunized with 50 mg of puri®ed rD emulsi®ed in complete Freund's adjuvant (CFA) in the hind footpad and in the base of the tail. Mice were boosted with the same amount of rD in incomplete Freund's adjuvant at day 21 and antibody assays were performed at day 28. For the analysis of serum autoantibodies, conventional ELISAs were performed utilizing native murine snRNP puri®ed from Ehrlich ascites cultured cells as previously described (39) .
Immunoprecipitation and immunoblotting
Immunoprecipitation assays for intracellular phosphorylation were performed as previously described (40) . Ten million puri®ed B cells as indicated above were incubated for 5 min at 37°C with anti-IgM (10 mg/ml) or rSm-D self-antigen (5 mg/ml) of RPMI 1640 without FCS. The cells were pelleted by centrifugation and lysed in 200 ml of RIPA buffer supplemented with 1 mM PMSF, 1 mM leupeptin, 100 mM NaF and 1 mM sodium orthovanadate. For the detection of Syk kinase phosphorylation, supernatants were incubated with 1 mg rabbit anti-Syk (C-20; Santa Cruz Biotechnology, Santa Cruz, CA) and 40 ml of Protein A/G±Sepharose for 90 min at 4°C. The Sepharose beads were pelleted, washed 3 times with RIPA buffer, suspended in SDS sample buffer and boiled for 5 min. The immunoprecipitates were analyzed on SDS±PAGE gel. Proteins were transferred onto nitrocellulose membranes and blotted with anti-phosphotyrosine antibody or anti-Syk antibody (Santa Cruz Biotechnology). In separate studies, wholecell lysates were probed for tyrosine phosphorylation. In brief, whole-cell lysates were resolved by 7.5% SDS±PAGE gel and blotted with anti-phosphotyrosine antibody (Santa Cruz Biotechnology) essentially as described (40) . The immunoreactive antibody was detected using the enhanced chemiluminescence system (Cell Signaling Technology, Beverly, MA).
Results
Anti-snRNP B cells are developmentally arrested in normal 2-12 Tg mice, but are activated in MRL-lpr/lpr mice As demonstrated in earlier studies, the 2-12 heavy chain transgene supports B cell development, but the majority of anti-snRNP B cells are of immature phenotype (32) . Overall, nearly 30% of Tg B cells are autoreactive, binding either snRNP or single-stranded DNA by¯ow cytometry (32, 41) . To investigate whether anti-snRNP B cells are activated and make autoantibodies, serum samples from Tg mice of different backgrounds were collected at regular intervals and autoantibody production was examined by ELISA. As indicated in a Sera (1:100 dilution) were tested at the same time levels of antisnRNP (Igm) using ELISA as described in Methods. b The OD values of one MRL-lpr mouse serum (as a standard used in all ELISA assays) were arbitrarily de®ned as 100 U. The units in different mice were obtained by the formula OD exp /OD std Q 100 (U).
c P 1 <0.001 for comparisons to wild-type B10.A mice; P 2 >0.05 for comparisons to the corresponding wild-type mice. Table 1 , Tg mice in B10.A and C57Bl/6 backgrounds could not make detectable anti-snRNP autoantibodies above levels found in the corresponding wild-type mouse strains (P 2 > 0.05). In contrast, Tg MRL-lpr/lpr mice spontaneously produce elevated amounts of anti-snRNP autoantibodies compared to wild-type B10.A mice (P 1 < 0.001). Antinuclear antibody assay also indicates that Tg B cells are activated in MRL-lpr/lpr, but not in the non-autoimmune-prone mice (Fig. 1) . The presence of autoantibody production indicates that the regulation of anti-snRNP B cell tolerance is not intact in MRL-lpr/lpr Tg mice. This also implied that endogenous T cell help and a source of endogenous snRNP autoantigen contributed to the autoantibody response. Conversely, the absence of spontaneous autoantibody production in Tg B10.A and C57Bl/6 mice suggested that T cell tolerance to the self-antigen was maintained and/or no source of self-antigen was available to drive the autoimmune responses.
Kidney pathology
Glomerulonephritis is one pathologic hallmark of SLE. To determine whether the anti-snRNP transgene would cause kidney pathology, we evaluated B10.A, C57Bl/6 and MRL-Fas/ lpr mice at various timepoints (2, 4 and 6 months of age). The examination of kidney sections from normal mice showed preservation of the renal architecture with normal vessels and glomeruli ( Fig. 2A and C) . B10.A or C57Bl/6 2-12 Tg mice show a similar pattern to those of normal wild-type mice ( Fig. 2B and D) .
The most striking aspects of the kidney pathology were found in MRL-lpr/lpr 2-12 Tg mice, where signi®cant interstitial accumulations of lymphocytes (Fig. 2F) were prominent beginning at 16 weeks of age. However, there was no evidence of endovasculitis in MRL-2-12 Tg mice. Control MRL-lpr/lpr mice (>16 weeks old) demonstrated large perivascular mixed lymphoid hyperplasia which included activated lymphocytes, plasma cells and mononuclear cells typical of pathology found in these mice (Fig. 2E) . The vessels showed marked myointimal proliferation and in®ltration of the myointimal region with lymphocytes.
Anti-snRNP B cells tolerize autoreactive T cells in normal Tg mice but activate D-protein-responsive T cells in autoimmune-prone mice
The importance of B cells as APC has been studied in our laboratory and others (11, 42) . To understand whether antisnRNP B cells can serve as autoantigen-presenting cells and to establish T cell tolerance or activation, we investigated the response of CD4 T cells from unimmunized C57BL/6 wild-type and Tg mice to the snRNP D protein in the presence of either wild-type or Tg APC. As described earlier, the Ig transgene was selected for its binding speci®city to the D protein component of the murine snRNP complex. As illustrated in Fig. 3 , CD4 T cells from wild-type C57Bl/6 mice did not respond to snRNP D protein presented by wild-type autologous APC. Surprisingly, wild-type C57Bl/6 CD4 T cells responded strongly to snRNP D protein presented by Tg APC (representative proliferative data from seven experiments), suggesting that unique peptides presented by Tg APC could activate autoimmune T cells from the normal repertoire of a non-autoimmune-prone mouse (Fig. 3A) . This simple observation suggests that the Tg B cells, by virtue of their surface receptor speci®city, presented a unique group of snRNP D peptides to which T cells in the wild-type mouse had never been exposed and thus had never been tolerized.
In contrast, CD4 T cells originating from Tg C57Bl/6 mice failed to respond signi®cantly to snRNP peptide presented by wild-type APC or by syngeneic Tg APC. The inability of CD4 T cells originating from Ig Tg mice to respond under these conditions suggests that Tg B cells (or their secreted antibody), in vivo, acted to tolerize T cells to the speci®c peptides that were displayed on its surface.
As in C57Bl/6 mice, CD4 T cells from wild-type or 2-12 Tg MRL-lpr/lpr mice failed to respond to snRNP D protein presented by wild-type syngeneic APC (Fig. 3B) . However, T cells from 2-12 Tg MRL-lpr/lpr proliferated strongly when exposed to peptides on Tg APC. MRL-lpr/lpr T cells, whether from a 2-12 Tg or wild-type source, require Tg APC to drive T cell proliferation. These results indicate that autoreactive T cells are not tolerized by Tg B cells in the MRL-lpr/lpr mouse, unlike the situation in non-autoimmune-prone mice.
snRNP D protein-reactive T cell hybridomas from MRL-lpr/ lpr 2-12 Tg mice
To further con®rm the speci®city of T cell responses described above, we generated T cell hybridomas from unmanipulated anti-snRNP Tg MRL-lpr/lpr mice. Sixty hybridomas were screened by staining for TCR and reactivity to a pool of snRNP D peptides presented by 2-12 Tg APC. Fourteen T cell hybridoma clones were found to respond to one or more snRNP D peptides and Tg APC. One representative hybridoma, designated clone 26, was isolated and found to respond to the snRNP D peptide (31±45) presented by 2-12 Tg APC (Fig. 4) . This observation formally demonstrates that snRNP-reactive T cells are not tolerized by the transgene-bearing B cells in MRL-lpr/lpr mice. In contrast, no snRNP-reactive T cell clones could by derived by similar methodology from Tg C57Bl/6 mice, further suggesting that tolerance was induced by endogenous anti-snRNP B cells (data not shown).
Immunization of C57Bl/6 Tg mice with snRNP D protein induces anti-snRNP antibody responses
We have demonstrated that all strains of 2-12 Tg mice have a signi®cant number of anti-snRNP D protein B cells in the periphery. However, no circulating anti-snRNP autoantibodies were found in C57Bl/6 or B10.A non-autoimmune-prone Tg mice. In contrast, 2-12 Tg MRL-lpr/lpr mice spontaneously secrete high titers of autoantibody. Prior studies demonstrated that immunization with intact snRNP particles in CFA could elicit autoantibody synthesis in Tg C57Bl/6 mice (32) . In the present studies we needed to con®rm that rD protein accurately represents the native autoantigen. Wild-type and 2-12 Tg C57Bl/6 mice were immunized with rD protein in CFA, boosted with rD protein in IFA on day 21, and antibody responses were examined at day 28. As seen in Fig. 5 , wild-type mice have no detectable autoantibodies after immunization with rD protein in a manner in which tolerance is observed after immunization with the native mouse snRNP particle (39) . No T cell responses can be elicited in wild-type mice (data not shown), suggesting (43, 44) ]. As discussed above, we have indicated that most of anti-snRNP B cells in normal mice are of an immature phenotype (32) . To determine if Syk phosphorylation is related to immature anti-snRNP B cell development, we puri®ed B cells from Tg or wild-type B10.A mice followed by stimulation with anti-IgM or rSm-D selfantigen. As indicated in Fig. 6(A) , anti-snRNP B cells were indistinguishable from resting Tg ± B cells in their ability to phosphorylate Syk upon anti-IgM stimulation (Fig. 6A, panel  B) . In contrast, anti-snRNP B cells exhibited Syk phosphorylation in response to rSm-D while no band was found in Tg ± mice (Fig. 6A, panel A) . B cells from either Tg or wild-type MRL-lpr/lpr mice (16±30 weeks) showed Syk kinase phosphorylation even without antigen stimulation indicating that endogenous self-antigen or other factors serve to stimulate B cell maturation (Fig. 6A, panel C) . It is not yet known if constitutive Syk phosphorylation in MRL-lpr/lpr mice is a function of Fas de®ciency. In addition, overall tyrosine phosphorylation is enhanced in activated anti-snRNP Tg B cells (Fig. 6B) . One band in particular was enhanced in lysates of Tg B cells (Fig. 6B, arrow) .
Discussion
The immune system has evolved a number of sophisticated mechanisms in order to direct the response of lymphocytes against foreign antigens while ignoring self-proteins. However, the presence of autoimmune diseases suggests that a balance exists between tolerance versus immunity to selfproteins. SLE represents one disease for which a failure of tolerance occurs. Autoimmunity in SLE is directed against a number of intracellular macromolecules including nucleosomes, DNA and snRNP (1), leading to pathology in the kidneys, skin and connective tissues. A number of prior studies have indicated that fundamental defects in B cell and T cell functions may be responsible for the autoimmune responses of SLE (45±47).
We have utilized mice made Tg for the heavy chain of an anti-snRNP autoantibody in order to amplify or exaggerate the cognate interactions of autoreactive B cells and T cells in microenvironments in vivo. Investigations from the Clarke laboratory have demonstrated that these self-reactive B cells are not deleted or anergic in the repertoire of mice (32) . Indeed, these B cells are responsive to stimulation with snRNP antigen to synthesize and secrete autoantibodies (32, 48) . The present study has examined the role of anti-snRNP B cells in providing tolerance and/or activating signals to autoreactive T cells.
Three important observations have arisen from these studies. Among the most important is the ®nding that autoreactive T cells inhabit the naive repertoire of normal mice (Fig. 3) . Second, a lack of both B and T cell tolerance is found in Tg MRL mice. In contrast, no spontaneous autoimmunity is found when the same transgene is placed in non-autoimmune-prone mice. T cell tolerance is induced in Tg C57B1/6 or Tg B10.A mice. Finally, autoreactive B cells can ®nd sources of snRNP autoantigens in both MRL and normal mice for uptake and presentation to T lymphocytes. Among these observations, it was surprising to ®nd that many snRNP-reactive T cells escape thymic and peripheral tolerance mechanisms in normal mice. We used Tg B cells as probes to identify and activate autoreactive T cells in the repertoire of wild-type C57B1/6 mice (Fig. 3) . Even in nonautoimmune mice, snRNP-reactive T cells have evaded negative selection in the thymus, tolerance induction in the periphery and have clearly not died by neglect. We hypothesize that T cells have avoided peripheral tolerance to some speci®c snRNP peptides in normal mice because they have never come in contact with Tg B cells presenting snRNP peptide. This assumption is supported by prior work from our laboratories demonstrating a lack of T cell tolerance to several synthetic peptides of the snRNP D protein when used as immunogens in normal strains of mice (39) . Here, however, we show responses to whole protein naturally processed by B cells. It is interesting to note that the immunodominant peptide found to activate T cell clones in the present work overlaps with a cryptic peptide immunogen found in our earlier studies (39) . We had originally found that autoantibodies and autoreactive T cells could be induced in mice by immunization with p26±40 of the snRNP D protein. T cell clones from unimmunized Tg mice analyzed in this study actively respond to an overlapping peptide at this site, p31±45 (Fig. 4) . While we have not identi®ed peptide sequences from the MHC class II cleft of Tg B cells, we instead utilized synthetic peptides to identify the ensuing autoreactive T cell speci®cities as an indirect re¯ection of the peptides presented by Tg B cells.
In observations similar to those we have reported here, autoreactive T cells have previously been identi®ed from the naive repertoire of mice and from humans without clinical autoimmune disease (49, 50) . Recent studies by Anderson et al. have found autoreactive T cells speci®c for a target peptide of experimental autoimmune encephalomyelitis in the naive lymphoid repertoire of all H-2 s strains of mice (49) . One target peptide of myelin proteolipid protein (PLP) was found to stimulate T cells from naive SJL, BALB/s and B10.S mice suggesting a failure of thymic negative selection for this autoantigen. T cells speci®c for other target autoantigens of multiple sclerosis including myelin basic protein, PLP and myelin oligodendrocyte glycoprotein have been found in the peripheral repertoire of normal humans (50) . From studies with TCR Tg animals, it is now clear that a large percentage of autoreactive T cells can escape negative selection in the thymus even in the presence of the deleting peptide ligand (51) . The logical question arises as to why a species with autoreactive T cells speci®c for lupus autoantigens or to experimental autoimmune encephalomyelitis antigens fails to develop spontaneous autoimmune disease. It is possible that these T cells either fail to develop into effector phenotypes or are subject to other peripheral regulatory T cells. Studies are underway in our laboratory to determine if Tg B cells that drive autoreactive T cell responses in MRL mice can provide the same T cell stimulus from the repertoire of MHC matched nonautoimmune strains of mice.
A limited autoreactive TCR speci®city was apparent from our analysis of hybrid clones derived from Tg MRL-lpr/lpr mice (Fig. 4 and data not shown) . This is most likely due to the fact that surface Ig speci®city of antigen-presenting B cells in¯u-ences the internal processing of proteins and shapes the repertoire of T cell responses. Several studies have demonstrated that the ®ne speci®city of surface Ig controls the patterns of antigen fragmentation and the subsequent repertoire of responding T cells (52±54). Moreover, the avidity of sIg binding to its ligand directly affects the ef®ciency of antigen presentation by B cells.
We have demonstrated that autoreactive B cells can be stimulated to secrete autoantibodies by providing selfantigen with CFA adjuvant. The co-stimulatory molecules B7-1 and B7-2 are known to play a pivotal role in determining the recognition of antigen by T cells and could lead to activation or anergy depending on their presence or absence. However, it does not appear that either B7-1 or B7-2 expression differences between nonautoimmune strains versus MRL-lpr/lpr re¯ect differences in T cell tolerance or activation (25, 26) . We do not yet know whether other potential co-stimulation ligand/receptor such as B7h/ICOS interactions may explain the differences in cognate B±T cell interactions in these mice although these investigations are underway.
Although it is still not clear why anti-snRNP B cells have differential roles in the induction of activation/tolerance of autoreactive T cells, our data suggest that it might be related to the different status of anti-snRNP B cells. Syk kinase has been demonstrated to play a crucial role in B cell activation and development (44) . Additionally, Syk kinase and BCR receptor both in¯uence BCR-mediated MHC class II-restricted antigen presentation (55) . Immunoprecipitation studies suggest that Syk kinase is constitutively phosphorylated in MRLlpr/lpr mice, indicating anti-snRNP B cells are by default in activation, presumably through circulating self-antigens. AntisnRNP B cells in the normal background mice have the same ability to acquire endogenous antigen. However, it is possible that the source or af®nity of endogenous antigen for BCR is not suf®cient to drive autoantibody synthesis.
In summary, we have demonstrated the ability of B lymphocytes as the primary autoantigen-presenting cells to elicit either T cell autoimmunity or tolerance depending on the background of mouse in which they exist. These differences in B cell functions do not appear to be dependent on the presence of conventional co-stimulation by B7-1 or B7-2. Importantly, the appropriate presentation of antigen by B cells can activate T cells from the periphery of normal animals indicating that the repertoire possesses signi®cant numbers of self-reactive T cells. The subject of future studies will be in determining how these self-reactive T cells are kept in check and prevented from driving pathologic autoimmune responses such as those found in SLE.
